Member Info for chrishutch

I spoke to the company who advised that 'We understand that seller has largely or wholly exited the position they needed to clear. However, we share your frustration with the share price performance'

Hopefully, on the next run up to the 3 level we will break it and start climbing higher.

Nice price opportunity here on the close, if it remains at this level on open then I will probably take some.

Could that finally be the seller out. Can't have much left if not. There was not a holder with the volume we have seen.

Anyone selling down here is nuts. I have had a good day elsewhere but watching people give their shares away down here makes me laugh. Just hang on it is worth twice, three times this

:-)
building a little position

Our time will come - and hopefully not much longer to wait

£2 to be crossed!

this bounced

We have a load of traders buying this in the 2.8s and selling in the 2.9s haha...

Eventually, they will miss out on a colossal rise for beer money

gaining a bit of interest. Any one any ideas why?

Once 3p goes it will be the floor. Not long now.

red to blue and about to climb higher

now you can't buy.... locked out.

Wow here we go

Looks like current over hang cleared, price moving up more freely. Fingers crossed we move back into 3s

It's cheap, price is nuts but it won't stay down here for long.

* Agreement with Conduit and SGSC to acquire a 5% economic interest for a total consideration of £1.88 million, to be settled in new Cizzle ordinary shares at a price of 4.0p per share, a 56.9% premium to the closing mid-market price on 11 February 2022

*in discussions with multiple pharmaceutical companies about licensing opportunities for AZD 1656 for Covid-19 and potentially for further indications

* expand its target customer base into the pharmaceutical industry

*significantly the Economic Interest will be uncapped

*a full commercial agreement has now been executed to develop and market the Company's proprietary early lung cancer diagnostic tests in China

* 10% royalty for the Company over all sales of products and services using CIZ1B in China

* At a target price of about £100 per test, the total available market for tests based on the CIZ1B biomarker would be £3 billion.

Given the news and the price action I have managed to get my average right down. Hopefully that will pay dividends on the run up to issue price of 4p and above.

Blu is blu

Very happy to see this up here!

Well Done all.

I have posted here quite a bit recently and will continue to while the opportunity to make money is so strong.

To be honest, it is is unheard of that the price remains here. It displays the market inefficiencies of retail investors and traders that the price of a company where the fundamentals are so strong that they can raise at 57% premium to the share price to acquire an uncapped stake alongside the China news.

I mean back of the fag packet calcs (for want of a cancer appropriate saying) show the Mcap is tiny.